Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

Trump Blasts “Corrupt” Media at Rambling Coronavirus Press Conference

HeadlineMar 20, 2020

At the White House, President Donald Trump sought to deflect criticism of his administration’s disastrous handling of the coronavirus crisis, lashing out at China and excoriating the media as “fake” and “corrupt news.” Reporters in Thursday’s White House press briefing sat in every other chair to increase social distancing. Faced with a barrage of critical questions, Trump threatened to empty the room even further.

President Donald Trump: “You’re actually sitting too close. You should — really, we should probably get rid of about another 75, 80% of you. I’ll have just two or three that I like in this room. I think that’s a great way of doing it. We just figured a new way of doing it. But you’re actually much too close. You know, you two, you should leave immediately.”

Trump gave the final question of Thursday’s press briefing to Chanel Rion, a Republican political operative with the far-right website One America News.

Chanel Rion: “Is it alarming that major media players, just to oppose you, are consistently siding with foreign state propaganda, Islamic radicals and Latin gangs and cartels, and they work right here at the White House with direct access to you and your team?”

During the press conference, Trump recommended the use of the anti-malarial drug chloroquine for patients suffering from COVID-19.

President Donald Trump: “We’re going to be able to make that drug available almost immediately. And that’s where the FDA has been so great. They’ve gone through the approval process. It’s been approved.”

Moments after Trump made those comments, FDA Commissioner Dr. Stephen Hahn denied his agency had approved chloroquine for COVID-19 treatment, saying the drug first needs to be tested in a large clinical trial. Rising Pharmaceuticals, the New Jersey-based company that produces chloroquine, doubled the price of the drug after Trump’s comments — before reversing its decision later Thursday.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation